Sequera, C.; Bragado, P.; Manzano, S.; Arechederra, M.; Richelme, S.; Gutiérrez-Uzquiza, A.; Sánchez, A.; Maina, F.; Guerrero, C.; Porras, A.
C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation. Cancers 2020, 12, 2282.
https://doi.org/10.3390/cancers12082282
AMA Style
Sequera C, Bragado P, Manzano S, Arechederra M, Richelme S, Gutiérrez-Uzquiza A, Sánchez A, Maina F, Guerrero C, Porras A.
C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation. Cancers. 2020; 12(8):2282.
https://doi.org/10.3390/cancers12082282
Chicago/Turabian Style
Sequera, Celia, Paloma Bragado, Sara Manzano, Maria Arechederra, Sylvie Richelme, Alvaro Gutiérrez-Uzquiza, Aránzazu Sánchez, Flavio Maina, Carmen Guerrero, and Almudena Porras.
2020. "C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation" Cancers 12, no. 8: 2282.
https://doi.org/10.3390/cancers12082282
APA Style
Sequera, C., Bragado, P., Manzano, S., Arechederra, M., Richelme, S., Gutiérrez-Uzquiza, A., Sánchez, A., Maina, F., Guerrero, C., & Porras, A.
(2020). C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation. Cancers, 12(8), 2282.
https://doi.org/10.3390/cancers12082282